You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Kawasaki syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Inflammatory Heart Diseases

Not yet recruiting
  • Myocarditis
  • +2 more
  • study of biological samples and echocardiographic data and link with need of hemodynamic support
  • Vandœuvre-lès-Nancy, France
    Gilles BOSSER
Jun 20, 2023

Kawasaki Disease, Coronary Aneurysm, Rivaroxaban Trial (Rivaroxaban Oral Tablet or Suspension [Xarelto], Aspirin or Clopidogrel,

Not yet recruiting
  • Kawasaki Disease
  • +4 more
  • Rivaroxaban Oral Tablet or Suspension [Xarelto]
  • +2 more
  • (no location specified)
Dec 6, 2022

Calcium Binding Protein S100A12 in Diagnosis and Prognosis of

Not yet recruiting
  • Diagnoses Disease
  • S100A12
  • (no location specified)
Jun 21, 2022

A Blood Test to Diagnose Kawasaki Disease

Not yet recruiting
  • Kawasaki Disease
    • (no location specified)
    Mar 25, 2022

    Clinical Precise Diagnosis and Treatment in the Kawasaki Disease

    Recruiting
    • Kawasaki Disease
    • Echocardiography, Genomics NGS sequencing
    • Nantong, Jangsu, China
    • +3 more
    Apr 24, 2022

    Multisystem Inflammatory Syndrome in Children and Its

    Recruiting
    • Kawasaki Disease
    • Inflammation
      • La Jolla, California
        University of California, San Diego
      Nov 12, 2021

      Kawasaki Disease Trial in Le Kremlin-Bicêtre (ANAKINRA, Intravenous immunoglobulin)

      Not yet recruiting
      • Kawasaki Disease
      • Le Kremlin-Bicêtre, Val De Marne, France
        CHU de Bicêtre
      Jun 17, 2022

      Kawasaki Disease Trial in San Diego (Anakinra)

      Active, not recruiting
      • Kawasaki Disease
      • San Diego, California
        Rady Children's Hospital San Diego
      Mar 1, 2022

      Kawasaki Disease Children With Coronary Artery Abnormalities

      Recruiting
      • Kawasaki Disease
      • Coronary Artery Abnormalities
        • Shanghai, Shanghai, China
          Children's Hospital of Fudan University
        Jan 6, 2022

        Kawasaki Disease Trial in San Diego (Atorvastatin and anakinra)

        Recruiting
        • Kawasaki Disease
        • Atorvastatin and anakinra
        • San Diego, California
          University of California San Diego
        Mar 1, 2022

        Kawasaki Disease Trial in China (IVIG, Aspirin, Prednisolone)

        Recruiting
        • Kawasaki Disease
        • Beijing, China
        • +14 more
        Jan 9, 2023

        Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial in Ireland, Japan (prasugrel Monotherapy)

        Recruiting
        • Chronic Coronary Syndrome
        • Non ST Segment Elevation Acute Coronary Syndrome
        • prasugrel Monotherapy
        • Galway, Ireland
        • +12 more
        Nov 1, 2022

        Sjögren's Syndrome Trial in Worldwide (Deucravacitinib, Placebo)

        Not yet recruiting
        • Sjögren's Syndrome
        • Santa Monica, California
        • +25 more
        Jul 19, 2023

        Guillain-Barre Syndrome Trial in Japan (Eculizumab, Placebo)

        Completed
        • Guillain-Barre Syndrome
        • Eculizumab
        • Placebo
        • Bunkyo-ku, Japan
        • +25 more
        Aug 26, 2022

        Kawasaki Disease Trial in Shanghai (IVIG, Aspirin, Infliximab)

        Withdrawn
        • Kawasaki Disease
        • Shanghai, China
        • +4 more
        Mar 10, 2021

        Hypereosinophilic Syndrome Trial in Worldwide (Benralizumab, Placebo)

        Recruiting
        • Hypereosinophilic Syndrome
        • Benralizumab
        • Placebo
        • La Jolla, California
        • +45 more
        Feb 2, 2023

        Primary Immunodeficiency Diseases (PID), Immune Thrombocytopenic Purpura (ITP), Kawasaki Syndrome Trial in United States (Immune

        Completed
        • Primary Immunodeficiency Diseases (PID)
        • +2 more
        • Immune Globulin Intravenous (Human), 10%
        • Los Angeles, California
        • +10 more
        Aug 22, 2021

        Mucocutaneous Lymph Node Syndrome Trial in United States (IVIG, Infliximab)

        Completed
        Has Results
        • Mucocutaneous Lymph Node Syndrome
        • Birmingham, Alabama
        • +28 more
        Nov 5, 2021

        Mucocutaneous Lymph Node Syndrome Trial in Kaohsiung City (Methylprednisolone Injection)

        Recruiting
        • Mucocutaneous Lymph Node Syndrome
        • Methylprednisolone Injection
        • Kaohsiung City, Taiwan
          Kaohsiung Chang Gung Memorial Hospital
        Aug 10, 2020

        Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

        Recruiting
        • Rare Disorders
        • +309 more
          • Sioux Falls, South Dakota
          • +1 more
          Jun 20, 2022

          Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)

          Recruiting
          • Macrophage Activation Syndrome
          • +6 more
          • Birmingham, Alabama
          • +41 more
          Jan 3, 2023

          Kawasaki Disease Trial in San Diego (Atorvastatin)

          Completed
          Has Results
          • Kawasaki Disease
          • San Diego, California
            University of California San Diego
          May 4, 2020

          Alport Syndrome Trial in Worldwide (Placebo Oral Capsule, Bardoxolone Methyl)

          Completed
          • Alport Syndrome
          • Placebo Oral Capsule
          • Bardoxolone Methyl
          • Birmingham, Alabama
          • +62 more
          Mar 22, 2022

          Vasculitis, Systemic, Kawasaki Disease Trial in Warsaw

          Recruiting
          • Vasculitis, Systemic
          • Kawasaki Disease
            • Warsaw, Poland
              Medical University of Warsaw Children's Hospital
            Nov 21, 2019

            Routine Health Insurance Data With Focus on Autoimmune Diseases

            Active, not recruiting
            • Virus Diseases
            • Exposed to a SARS-CoV-2 infection
            • Dresden, Saxony, Germany
              Center for Evidence-Based Healthcare, Technische Universität Dre
            Jan 25, 2023